(Q43264238)

17 November 2017

title

Charcot-Marie-Tooth disease type 1A: is ascorbic acid effective? (English)

1 reference

Charcot-Marie-Tooth disease type 1A

17 November 2017

main subject

1 reference

Davide Pareyson

1

1 reference

17 November 2017

Alessandra Solari

series ordinal

2

1 reference

17 November 2017

publication date

7 October 2009

1 reference

17 November 2017

1 reference

17 November 2017

volume

8

1 reference

17 November 2017

issue

12

1 reference

17 November 2017

page(s)

1075-1077

1 reference

Diagnosis, natural history, and management of Charcot–Marie–Tooth disease

17 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970270-4

7 January 2021

Ascorbic acid treatment corrects the phenotype of a mouse model of Charcot-Marie-Tooth disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970270-4

7 January 2021

Effect of ascorbic acid in patients with Charcot-Marie-Tooth disease type 1A: a multicentre, randomised, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970270-4

7 January 2021

Reliability and validity of the CMT neuropathy score as a measure of disability.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970270-4

7 January 2021

Ascorbic acid for Charcot-Marie-Tooth disease type 1A in children: a randomised, double-blind, placebo-controlled, safety and efficacy trial.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970270-4

7 January 2021

Poor tolerability of high dose ascorbic acid in a population of genetically confirmed adult Charcot-Marie-Tooth 1A patients

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970270-4

7 January 2021

Neuropathy progression in Charcot-Marie-Tooth disease type 1A

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970270-4

7 January 2021

136th ENMC International Workshop: Charcot-Marie-Tooth disease type 1A (CMT1A)8-10 April 2005, Naarden, The Netherlands

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970270-4

7 January 2021

Reliability of clinical outcome measures in Charcot-Marie-Tooth disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970270-4

7 January 2021

A multicenter, randomized, double-blind, placebo-controlled trial of long-term ascorbic acid treatment in Charcot-Marie-Tooth disease type 1A (CMT-TRIAAL): The study protocol [EudraCT no.: 2006-000032-27]

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970270-4

7 January 2021

A brief history of research synthesis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970270-4

7 January 2021

10.1016/S1474-4422(09)70270-4

Identifiers

DOI

1 reference

release_44c5on3y4zhnzo762yapgbaay4

17 November 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/44c5on3y4zhnzo762yapgbaay4

24 November 2022

mapped directly with Wikidata item

1 reference